FDA Inspection 1245609 — American Red Cross Blood Services Southwest Region

American Red Cross Blood Services Southwest Region — FEI 3006805687

The FDA completed an inspection of American Red Cross Blood Services Southwest Region on Jul 11, 2024 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jul 11, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Dallas, TX (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.